Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy is a research paper published in Gastroenterology (2023). On theSindex it has a DataRank of 1.8. It has been cited 71 times, with 65 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.641
From this paper's citation signal
Citation Network Contribution
1.2
From 50 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 65 citers.
National Cancer Institute
Grant: 1 U01 CA274276-01
National Cancer Institute
Grant: U01 CA224146-01
National Institute of Allergy and Infectious Diseases
Grant: 1R01AI158488-01
NIAID NIH HHS
Grant: R01 AI158488
NIGMS NIH HHS
Grant: T32 GM144273
NIDDK NIH HHS
Grant: K08 DK114563
NCI NIH HHS
Grant: R01 CA177684
NIGMS NIH HHS
Grant: T32 GM007753
NCI NIH HHS
Grant: U01 CA224146
NCI NIH HHS
Grant: R01 CA276268
NCI NIH HHS
Grant: T32 CA207021
NCI NIH HHS
Grant: U01 CA274276
Hale Family Center for Pancreatic Cancer Research
National Institutes of Health
Pancreatic Cancer Action Network
Ludwig Center at Harvard
Novartis Institutes for BioMedical Research
Dana-Farber Cancer Institute
Novartis Pharmaceuticals Corporation
MeSH Terms
Keywords